Vanko Biotech Private Limited
About Vanko Biotech Private Limited
Data last updated:
Vanko Biotech Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24234TG2019PTC130043. Its GSTIN is 36AAGCV7768R1Z4 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Venkata Surya Srinivasa Reddy Medapati and Supriya Medapati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.35 H.No.25 – 29/18/55/1 Sri Sai Nagar Colony Ramchandrapuram, Hyderabad, Telangana, India – 502032.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.81 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹7,825 (net margin 2.8%) and EBITDA of ₹69,734 (EBITDA margin 24.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vanko Biotech Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.35 H.No.25 – 29/18/55/1 Sri Sai Nagar Colony Ramchandrapuram, Hyderabad, Telangana, India – 502032
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Vanko Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vanko Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vanko Biotech Private Limited, buy the company report.
Financials of Vanko Biotech Private Limited
FY 2025 filings availableVanko Biotech Private Limited reported revenue of ₹2.81 Lakh (up 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 19% in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹69,734 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,825 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.9% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vanko Biotech Private Limited, buy the company report.
Board of directors of Vanko Biotech Private Limited
Vanko Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Surya Srinivasa Reddy Medapati | Director | 25 Jan 2019 | 7 Years 9 Months | Current |
| Supriya Medapati Also directs: Aerolyma Private Limited, Veneela Private Limited | Director | 25 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Vanko Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ask Pharma India Private Limited | ₹2.82 Lakh (FY 2019) | -29.0% | Hyderabad, Telangana, India | |||
| Icolor Chem Tech Private Limited | ₹2.81 Lakh (FY 2017) | 1.0% | Ahmedabad, Gujarat, India | |||
| Pineal Bioscience Private Limited | ₹2.81 Lakh (FY 2023) | -77.0% | Vadodara, Gujarat, India | |||
| Parkway Crop Science Private Limited | ₹2.81 Lakh (FY 2025) | -62.0% | Patna, Bihar, India | |||
| Biokin Healthcare Private Limited | ₹2.81 Lakh (FY 2024) | 545.0% | Dehradun, Uttarakhand, India | |||
| Vanko Biotech Private Limitedthis company | ₹2.81 Lakh (FY 2024) | ₹7,825 | 2.8% | 19.0% | Hyderabad, Telangana, India | |
| Bonarick Pharmaceutical Private Limited | ₹2.79 Lakh (FY 2022) | Guwahati, Assam, India | ||||
| Vigagen Pharma Private Limited | ₹2.78 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Biokinesis Healthcare Private Limited | ₹2.78 Lakh (FY 2022) | Haridwar, Uttarakhand, India | ||||
| Freshaler Private Limited | ₹2.78 Lakh (FY 2025) | -12.0% | Ahmedabad, Gujarat, India | |||
| Vijayalakshmi Laboratories Private Limited | ₹2.78 Lakh (FY 2016) | 7.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Vanko Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vanko Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vanko Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vanko Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCV7768R1Z4 | Telangana | Active | 26 Mar 2021 |
To see the full GST registrations and return filing status of Vanko Biotech Private Limited, buy the company report.
Recent activity
Vanko Biotech Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Subbaraju Gottumukkala ceased to be Director on 03 Mar 2022.
Frequently asked questions
Vanko Biotech is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 January 2019 (7+ years old) and is registered under CIN U24234TG2019PTC130043.
Vanko Biotech has 2 current directors:
- Venkata Surya Srinivasa Reddy Medapati - Director
- Supriya Medapati - Director
The latest financial statements of Vanko Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Vanko Biotech is 36AAGCV7768R1Z4, registered in Telangana.
The CIN (Corporate Identification Number) of Vanko Biotech is U24234TG2019PTC130043. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vanko Biotech was incorporated on 25 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Vanko Biotech by revenue are Ask Pharma India Private Limited, Icolor Chem Tech Private Limited, Pineal Bioscience Private Limited, Parkway Crop Science Private Limited, Biokin Healthcare Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Subbaraju Gottumukkala ceased to be Director on 03 Mar 2022. Vijaya Laxmi Gottumukkala ceased to be Director on 03 Mar 2022. Supriya Medapati was appointed as Director on 25 Jan 2019. Vanko Biotech has 4 board changes on record in total.
The registered office of Vanko Biotech is at Plot No.35 H.No.25 – 2918551 Sri Sai Nagar Colony Ramchandrapuram, Hyderabad, Telangana, India – 502032.
Vanko Biotech operates in the chemicals industry, in the manufacturing segment.
The compliance status of Vanko Biotech is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
